Tradestie Institutional Equity Comparison Engine
TCMD vs ECOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TCMD Overall Edge
TCMD Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TCMD trades at 17.4x Forward P/E with 9.4% operating margin (+7.1% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
TCMD
TCMD 17.4x vs ECOR N/M Fwd P/E
Growth & Margin Winner
TCMD
Op Margin 9.4% vs -33.1% ยท YoY +7.1% vs +11.5%
Momentum & Technical Winner
TCMD
1Y +5.7% vs -9.4% ยท 52W Pos 29% vs 6%
Options & Structure Winner
TCMD
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (N/A IV)
TCMD
NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.60
-1.5% 1D
Market Cap
$582.2M
1M Return
+8.75%
1Y Return
+5.65%
Forward P/E
17.4x
Unified AI Score
40.1 / 100
SELL
Tech 37.0
Fund 44.0
Flow 65.0
Mom 31.1
ECOR
NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
-8.87% 1D
Market Cap
$44.7M
1M Return
-40.35%
1Y Return
-9.43%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 30.0
Fund 60.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TCMD +5.65%
ECOR -9.43%
Spread: +15.08 pp (TCMD Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TCMD Revenue | ECOR Revenue | TCMD Op. Margin | ECOR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $140M | $0M | 2.1% | -5494.1% | TCMD |
| FY2019 | $190M | $0M | 5.5% | -1928.2% | TCMD |
| FY2020 | $190M | $0M | -1.9% | -707.9% | TCMD |
| FY2021 | $210M | $10M | -0.8% | -367.7% | TCMD |
| FY2022 | $250M | $10M | -5.2% | -266.2% | TCMD |
| FY2023 | $270M | $20M | 6.6% | -120.2% | TCMD |
| FY2024 | $290M | $30M | 7.6% | -48.3% | TCMD |
| FY2025 | $330M | $30M | 8.9% | -41.1% | TCMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TCMD | ECOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $582.2M | $44.7M | Larger Scale | TCMD |
| Trailing P/E Ratio Valuation | 25.2x | N/M | Lower Multiple | TCMD |
| Forward P/E Ratio Valuation | 17.4x | N/M | Lower Multiple | TCMD |
| Revenue Growth (YoY) Growth | +7.1% | +11.5% | Higher Growth | ECOR |
| Operating Margin (TTM) Profitability | 9.4% | -33.1% | Higher Margin | TCMD |
| Net Profit Margin Profitability | 6.7% | -33.5% | Higher Margin | TCMD |
| Return on Equity (ROE) Capital Efficiency | 11.0% | -478.7% | Higher ROE | TCMD |
| 52-Week Range Position Momentum | 29% ($21โ$38) | 6% ($4โ$13) | Stronger Trend | TCMD |
| Beta / 30D Volatility Risk Regime | 0.95ฮฒ ยท 52% Vol | 1.55ฮฒ ยท 155% Vol | Lower Realized Risk | TCMD |
| Unified Institutional Score Composite Signal | 40.1 / 100 (SELL) | 44.5 / 100 (HOLD) | Higher Composite | ECOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TCMD vs ECOR Buy Guide
TCMD
CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
ECOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TCMD nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.